Related Experiment Videos
Cell wall targets in methicillin-resistant staphylococci.
Harald Labischinski1, Lars Johannsen
1Pharma Research Center, Wuppertal, Germany
Summary
Multiresistant staphylococci infections are a growing concern. New therapeutic targets, like those in staphylococcal cell wall synthesis, are urgently needed to combat resistant bacterial strains.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Multiresistant staphylococci, including methicillin-resistant Staphylococcus aureus (MRSA), present a significant threat in hospital settings.
- Vancomycin resistance in staphylococci necessitates the development of novel antimicrobial agents and therapeutic strategies.
- Traditional drug discovery methods are being replaced by rational approaches targeting essential bacterial-specific genes and proteins.
Purpose of the Study:
- To identify and evaluate novel therapeutic targets for combating multiresistant staphylococcal infections.
- To explore the potential of bacterial cell wall synthesis and remodeling pathways as targets for new antimicrobial drugs.
- To introduce specific genes involved in pentaglycine interpeptide bridge formation as promising targets.
Main Methods:
- Review of existing literature on potential antimicrobial targets in staphylococci.
- Identification and characterization of genes crucial for staphylococcal cell wall biosynthesis, specifically the pentaglycine interpeptide bridge.
- Analysis of the 'drugability' of bacterial cell wall components.
Main Results:
- The bacterial cell wall, a prokaryote-specific structure, offers a rich source of potential antimicrobial drug targets.
- Several targets within cell wall synthesis pathways remain underexploited for anti-staphylococcal therapy.
- Genes involved in the pentaglycine interpeptide bridge formation have been identified as promising targets.
Conclusions:
- Targeting the staphylococcal cell wall synthesis pathway, particularly the pentaglycine interpeptide bridge, presents a viable strategy against multiresistant staphylococci.
- The rational drug design approach focusing on essential bacterial-specific targets is crucial for overcoming antimicrobial resistance.
- Further research into these novel targets could lead to the development of effective treatments for challenging staphylococcal infections.